Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
1(13%)
Results Posted
40%(2 trials)

Phase Distribution

Ph phase_2
1
13%
Ph not_applicable
7
88%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
1(12.5%)
N/ANon-phased studies
7(87.5%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

8

all time

Status Distribution
Active(1)
Completed(5)
Other(2)

Detailed Status

Completed5
unknown2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
1
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (12.5%)
N/A7 (87.5%)

Trials by Status

unknown225%
active_not_recruiting113%
completed563%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
OTHER
Total Trials
8